Pediatrics
FDA/CDC
CDC: Zika-exposed newborns need intensified eye, hearing, and neurological testing
Findings of postnatal onset of symptoms has prompted new Zika management guidelines for infants.
Conference Coverage
Everolimus has long-term efficacy in tuberous sclerosis complex
The mTOR inhibitor is the first antiepilepsy drug to be selected for its mechanism of action.
Video
W. Curt LaFrance Jr, MD
Dr. LaFrance reviews the causes, diagnosis, treatment, and prognosis of psychogenic nonepileptic seizures in children.
From the Journals
Gene therapy for cerebral adrenoleukodystrophy shows promise
A majority of boys had stabilization of lesion progression and no major functional disability.
Feature
Five takeaways from Congress’ failure to extend funding for children’s coverage
Congress finally seems ready to take action on the Children’s Health Insurance Program after funding lapsed Sept. 30.
Conference Coverage
ADHD meds don’t raise seizure risk in epilepsy patients
Seizure risk was actually significantly lower for individual patients while on ADHD medication.
Conference Coverage
Subtle hearing loss after concussion could impair learning
Researchers assessed children with normal hearing after a concussion and found deficits in auditory processing that might not be apparent – and...
Conference Coverage
Soccer-playing girls 5 times more likely to return to same-day play after concussion
Increased likelihood for return to play stacks on top of increased risk of concussion for girls in soccer.
FDA/CDC
Briviact gets monotherapy approval for partial-onset seizures
New indication is based on extrapolation of trials data as an adjunctive treatment.
Latest News
Aptiom approved for pediatric partial-onset seizures
The antiepileptic was previously approved for partial-onset seizures in adults.
Literature Review
Blood Test Accurately Detects GLUT1 Deficiency Syndrome
A blood test can detect glucose transporter type 1 (GLUT1) deficiency syndrome accurately and rapidly, according to a brief communication...